ConductScience.org, home

Paper3300530

Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.

Pangon B and 7 others. Antimicrob Agents Chemother, 1987. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy. Papers, record 3300530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3300530

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1987
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.67
iCite
Revised in PubMed
2021-05-26
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pangon BB
2Joly VV
3Vallois JMJ M
4Abel LL
5Buré AA
6Brion NN
7Contrepois AA
8Carbon CC

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CefotaximeMajor topic
CeftriaxoneMajor topic
Endocarditis, BacterialMajor topic
Escherichia coliMajor topic
Escherichia coli InfectionsMajor topic
Animals
Cefmenoxime
Cefotiam
Drug Evaluation, Preclinical
Kinetics
Rabbits

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14492776Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.J Clin Invest1974https://conductscience.org/library/papers/4492776PubMed
23710965Novel approaches for the use of aminoglycosides: the value of experimental models.J Antimicrob Chemother1986https://conductscience.org/library/papers/3710965PubMed
31086635New method for detecting in vitro inactivation of penicillins by Haemophilus influenzae and Staphlycoccus aureus.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1086635PubMed
46260870Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.J Infect Dis1981https://conductscience.org/library/papers/6260870PubMed
57013003Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo.Rev Infect Dis1981https://conductscience.org/library/papers/7013003PubMed
67033400Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration.J Infect Dis1982https://conductscience.org/library/papers/7033400PubMed
76275779Pharmacokinetics of ceftriaxone in humans.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6275779PubMed
86282203Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6282203PubMed
96297387Pharmacokinetics of cefotiam in normal humans.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6297387PubMed
106826714Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.J Clin Invest1983https://conductscience.org/library/papers/6826714PubMed
116316841Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6316841PubMed
123878128Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3878128PubMed
133510263Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics.J Infect Dis1986https://conductscience.org/library/papers/3510263PubMed
144091526Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/4091526PubMed
153516963Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis.J Antimicrob Chemother1986https://conductscience.org/library/papers/3516963PubMed
161117194Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.J Infect Dis1975https://conductscience.org/library/papers/1117194PubMed

Download CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
35056123FDA-Approved Oximes and Their Significance in Medicinal Chemistry.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35056123PubMed
11302801
In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11302801PubMed
7695248Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7695248PubMed
3324957Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3324957PubMed
3293977Cefotaxime optimal dosage in adult patients. A reappraisal.Drugs1988https://conductscience.org/library/papers/3293977PubMed
3282748Pulse dosing versus continuous infusion of antibiotics. Pharmacokinetic-pharmacodynamic considerations.Clin Pharmacokinet1988https://conductscience.org/library/papers/3282748PubMed
3048974Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.Drugs1988https://conductscience.org/library/papers/3048974PubMed
2665645Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2665645PubMed
2226482Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage.Eur J Clin Microbiol Infect Dis1990https://conductscience.org/library/papers/2226482PubMed
2188586Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2188586PubMed
2073099Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2073099PubMed
2069381Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/2069381PubMed
1759831Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1759831PubMed
1329634Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1329634PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3300530

GET https://conductscience.org/api/papers/v1/3300530/authors